Why is Ipca Labs falling/rising?

As of 15-Jul, Ipca Laboratories Ltd's stock is currently priced at 1,465.80, reflecting an increase of 8.55, or 0.59%. The stock has shown a positive trend recently, gaining 1.19% over the last two days, although it has underperformed its sector by 0.66% today. Over the past month, the stock has risen by 7.09%, significantly outperforming the year-to-date return of -13.35%. The company has reported positive results for the last four consecutive quarters, with a notable growth in profit after tax of 119.56% over the latest six months, and a high return on capital employed of 17.10%. Additionally, the stock benefits from a low debt-to-equity ratio and high institutional holdings at 46.82%, which suggests strong investor confidence and capability in analyzing the company's fundamentals.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has outperformed the Sensex over the past year with a return of 19.32% compared to the benchmark's 2.36%. However, in the short term, the stock's performance has been relatively flat, with a slight decline of 0.01% over the past week while the Sensex has dropped by 1.36%. Despite this, the rising investor participation, indicated by a 23.17% increase in delivery volume, suggests a growing interest in the stock, which may contribute to its recent upward price movement.